Biopatent Law: European vs. US Patent Law

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.

List of contents

Preface.- Ulrich Storz: Patentability Requirements of Biotech Patents.- Martin Quodbach: Law Enforcement of Biotech Patents.- Scott D. Marty, Derek E. Constantine and Matthew Parker: Particular: Aspects of US Patent Law in Biotechnologies.- About the Authors.

Summary

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.

Product details

• Authors: Derek E. Constantine, Scott D. Marty, Matthew Parker, Martin Quodbach, Ulrich Storz
• Publisher: Springer, Berlin
• Languages: English
• Product format: Paperback / Softback
• Released: 04.12.2013
• EAN: 9783642412929
• ISBN: 978-3-642-41292-9
• No. of pages: 69
• Dimensions: 157 mm x 233 mm x 7 mm
• Weight: 146 g
• Illustrations: VIII, 69 p. 7 illus., 5 illus. in color.
• Series: SpringerBriefs in Biotech Patents
• Subjects: Natural sciences, medicine, IT, technology > Medicine > Non-clinical medicine; C, Law, Life Sciences, biochemistry, molecular biology, Mass Media, Biomedical and Life Sciences, Biochemistry, general, Entertainment & media law, IT Law, Media Law, Intellectual Property, Biomedical Research, Molecular Medicine